Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ephedra working group recommendations should be implemented -- industry coalition.

This article was originally published in The Tan Sheet

Executive Summary

FDA IMPLEMENTATION OF EPHEDRA WORKING GROUP RECOMMENDATIONS ENCOURAGED by supplement industry groups in a joint position paper on ephedra safety released Aug. 22. "The dietary supplement industry urges FDA to implement the recommendations of the ephedra working group to help assure the safety of ephedra-containing products intended for legitimate dietary supplement uses," the paper says.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel